Myostatin and Activin antagonists for the treatment of Sarcopenia

• 1. 用于治疗肌肉减少症的肌肉生长抑制素或激活素拮抗剂 [P] . 中国专利： CN106999589A . 2017-08-01
• 2. 抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其用途 [P] . 中国专利： CN113912718A . 2022-01-11
• 3. Myostatin or activin antagonists for the treatment of sarcopenia [P] . AU2019200082A1 . 2019-01-31

  机译： 肌生长抑制素或激活素拮抗剂治疗少​​肌症

• 4. myostatin or activin antagonists for the treatment of sarcopenia [P] . BR112017011411A2 . 2018-02-14

  机译： 肌生成抑制素或激活素拮抗剂治疗少​​肌症

• 5. MYOSTATIN OR ACTIVIN ANTAGONISTS FOR THE TREATMENT OF SARCOPENIA [P] . TN2017000217A1 . 2018-10-19

  机译： 肌抑制素或ACTIVIN拮抗剂治疗肌肉萎缩症

• 1. Progesterone Receptor Antagonists-A Novel Treatment for Severe Hyponatremia from the Endocrine Paraneoplastic Syndrome [J] . Jerome H.Check, Diane L.Check, Michael P.Dougherty 内分泌系统研究(英文) . 2021,第002期
• 2. EVALUATION OF THE INTRA-INDIVIDUAL VARIABILITY OF MYOSTATIN AND ACTIVIN A, TWO BIOMARKERS OF SARCOPENIA: IMPACT ON THE LEAST SIGNIFICANT CHANGE AND FOLLOWUP OF THE PATIENTS [J] . Cavalier E., Piron C., Watar F., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2016,第Suppla1期
• 3. Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women [J] . Mary Brinkoetter, Faidon Magkos, Maria Vamvini, American Journal of Physiology . 2011,第1Parta1期
• 4. Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone [J] . Andrea Iskenderian, Nan Liu, Qingwei Deng, Skeletal Muscle . 2018,第1期
• 5. A robot instructor for the prevention and treatment of Sarcopenia in the aging population: a pilot study [C] . M. Bogliolo, G. Marchesi, A. Germinario, IEEE International Conference on Robot and Human Interactive Communication . 2020
• 6. Studies on the Survival of Ovarian Cancer Cells Following Treatment with Beta-Adrenergic Receptor Agonists and Antagonists [D] . Horan, Noah Patrick. 2020
• 7. Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women [O] . Mary Brinkoetter, Faidon Magkos, Maria Vamvini, -1
• 8. A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities [O] . Danielle Vaughan, Robert Mitchell, Oliver Kretz, 2021

• 1. Activins and activin antagonists in hepatocellular carcinoma [J] . Alev Deli ,Emanuel Kreidl ,Stefan Santifaller . 世界胃肠病学杂志：英文版 . 2008,第11期
• 2. Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia [J] . Xiao-Yu Ma ,Fen-Qin Chen . 世界临床病例杂志 . 2021,第033期
• 3. Endothelin receptor antagonists for the treatment of diabetic nephropathy:A meta-analysis and systematic review [J] . Li Zhang ,Shuai Xue ,Jie Hou . 世界糖尿病杂志：英文版（电子版） . 2020,第11期
• 4. Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer [J] . Yan Yan ,Hong-Wei Lin ,Zhuo-Nan Zhuang . 世界胃肠肿瘤学杂志：英文版（电子版） . 2020,第8期
• 5. 针刺顶颞前斜线中2/5配合运动疗法治疗中风后遗症肱二头肌肌力降低 [C] . 陈家林 . 第十届北京国际康复论坛 . 2015
• 6. “筋骨并重”理论指导下腰痛康结合运动处方治疗肌少--骨质疏松症 [A] . 周琦 . 2020